Non-invasive Multimodality Imaging of Coronary Vulnerable Patient.

chronic coronary syndrome coronary artery disease multimodal imaging risk stratification vulnerable patient vulnerable plaque

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2022
Historique:
received: 15 12 2021
accepted: 01 02 2022
entrez: 14 3 2022
pubmed: 15 3 2022
medline: 15 3 2022
Statut: epublish

Résumé

Atherosclerotic plaque rupture or erosion remain the primary mechanism responsible for myocardial infarction and the major challenge of cardiovascular researchers is to develop non-invasive methods of accurate risk prediction to identify vulnerable plaques before the event occurs. Multimodal imaging, by CT-TEP or CT-SPECT, provides both morphological and activity information about the plaque and cumulates the advantages of anatomic and molecular imaging to identify vulnerability features among coronary plaques. However, the rate of acute coronary syndromes remains low and the mechanisms leading to adverse events are clearly more complex than initially assumed. Indeed, recent studies suggest that the detection of a state of vulnerability in a patient is more important than the detection of individual sites of vulnerability as a target of focal treatment. Despite this evolution of concepts, multimodal imaging offers a strong potential to assess patient's vulnerability. Here we review the current state of multimodal imaging to identify vulnerable patients, and then focus on emerging imaging techniques and precision medicine.

Identifiants

pubmed: 35282382
doi: 10.3389/fcvm.2022.836473
pmc: PMC8907666
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

836473

Informations de copyright

Copyright © 2022 Canu, Broisat, Riou, Vanzetto, Fagret, Ghezzi, Djaileb and Barone-Rochette.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Am Coll Cardiol. 2017 Apr 11;69(14):1774-1791
pubmed: 28385306
J Clin Endocrinol Metab. 2007 Mar;92(3):1023-33
pubmed: 17164304
PLoS One. 2017 Aug 24;12(8):e0183514
pubmed: 28837682
J Am Coll Cardiol. 2009 Jun 2;53(22):2039-50
pubmed: 19477353
Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1616-1625
pubmed: 31004184
J Am Coll Cardiol. 2015 Mar 3;65(8):846-855
pubmed: 25601032
N Engl J Med. 2007 Apr 12;356(15):1503-16
pubmed: 17387127
JACC Cardiovasc Imaging. 2010 Apr;3(4):388-97
pubmed: 20394901
EJNMMI Res. 2019 Jan 7;9(1):3
pubmed: 30617563
Eur Heart J. 2017 Feb 14;38(7):500-507
pubmed: 27252451
J Am Coll Cardiol. 2009 May 5;53(18):1708-15
pubmed: 19406347
J Biomed Opt. 2006 Mar-Apr;11(2):021002
pubmed: 16674177
J Cardiovasc Comput Tomogr. 2021 May-Jun;15(3):218-225
pubmed: 33358186
JACC Cardiovasc Imaging. 2009 May;2(5):637-47
pubmed: 19442953
Front Cardiovasc Med. 2021 Jul 05;8:692915
pubmed: 34291095
Front Cardiovasc Med. 2021 Sep 22;8:736223
pubmed: 34631834
Heart. 2016 Oct 15;102(20):1655-61
pubmed: 27302987
Semin Thromb Hemost. 2020 Jul;46(5):545-552
pubmed: 31096311
J Cardiovasc Comput Tomogr. 2017 Mar - Apr;11(2):157-168
pubmed: 28283309
J Am Heart Assoc. 2017 Aug 23;6(8):
pubmed: 28838916
Circulation. 2000 Aug 1;102(5):506-10
pubmed: 10920061
Circulation. 2005 Jun 28;111(25):3481-8
pubmed: 15983262
Circulation. 2003 Oct 7;108(14):1664-72
pubmed: 14530185
J Am Coll Cardiol. 2017 May 30;69(21):2657-2664
pubmed: 28545640
N Engl J Med. 2019 Dec 26;381(26):2497-2505
pubmed: 31733140
JACC Cardiovasc Imaging. 2018 Oct;11(10):1475-1484
pubmed: 29909109
Lancet. 2018 Sep 15;392(10151):929-939
pubmed: 30170852
J Am Coll Cardiol. 2020 Aug 11;76(6):755-757
pubmed: 32762910
Eur Heart J. 2019 Nov 1;40(41):3421-3433
pubmed: 31566246
JAMA Cardiol. 2018 Feb 1;3(2):144-152
pubmed: 29322167
J Cardiovasc Comput Tomogr. 2018 Jan - Feb;12(1):67-73
pubmed: 29233634
Clin Res Cardiol. 2018 Aug;107(Suppl 2):49-54
pubmed: 29948289
Nat Rev Cardiol. 2017 Jan;14(1):21-29
pubmed: 27762311
Arterioscler Thromb Vasc Biol. 2000 May;20(5):1262-75
pubmed: 10807742
Diab Vasc Dis Res. 2010 Jan;7(1):69-72
pubmed: 20368235
N Engl J Med. 2020 Nov 5;383(19):1838-1847
pubmed: 32865380
J Comput Assist Tomogr. 1999 Jan-Feb;23(1):16-8
pubmed: 10050800
N Engl J Med. 2011 Jan 20;364(3):226-35
pubmed: 21247313
J Am Coll Cardiol. 2006 Nov 7;48(9):1818-24
pubmed: 17084256
Lancet. 2014 Feb 22;383(9918):705-13
pubmed: 24224999
Semin Nucl Med. 2021 Nov 22;:
pubmed: 34823841
J Am Coll Cardiol. 2007 May 8;49(18):1860-70
pubmed: 17481445
J Nucl Cardiol. 2017 Jun;24(3):1075-1084
pubmed: 26951555
J Am Coll Cardiol. 2010 Apr 13;55(15):1590-7
pubmed: 20378076
Circulation. 2020 May 5;141(18):1452-1462
pubmed: 32174130
Circ Cardiovasc Imaging. 2015 Feb;8(2):e002332
pubmed: 25666717
Arch Cardiovasc Dis. 2020 Jan;113(1):1-4
pubmed: 31899110
Sci Transl Med. 2017 Jul 12;9(398):
pubmed: 28701474
J Am Coll Cardiol. 2019 Jan 29;73(3):291-301
pubmed: 30678759
J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C13-8
pubmed: 16631505
Eur Heart J Cardiovasc Imaging. 2020 Jun 1;21(6):673-682
pubmed: 31408105
Am J Cardiol. 1991 Sep 3;68(7):36B-50B
pubmed: 1892066
Nat Rev Cardiol. 2009 Jul;6(7):475-81
pubmed: 19506587
J Am Coll Cardiol. 2007 Sep 18;50(12):1161-70
pubmed: 17868808
Eur Heart J Cardiovasc Imaging. 2019 Nov 1;20(11):1250-1258
pubmed: 30838375

Auteurs

Marjorie Canu (M)

Department of Cardiology, University Hospital, Grenoble Alpes, Grenoble, France.

Alexis Broisat (A)

Univ. Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, Grenoble, France.

Laurent Riou (L)

Univ. Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, Grenoble, France.

Gerald Vanzetto (G)

Department of Cardiology, University Hospital, Grenoble Alpes, Grenoble, France.
Univ. Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, Grenoble, France.
French Alliance Clinical Trial, French Clinical Research Infrastructure Network, Paris, France.

Daniel Fagret (D)

Univ. Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, Grenoble, France.
Department of Nuclear Medicine, University Hospital, Grenoble Alpes, Grenoble, France.

Catherine Ghezzi (C)

Univ. Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, Grenoble, France.

Loic Djaileb (L)

Univ. Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, Grenoble, France.
Department of Nuclear Medicine, University Hospital, Grenoble Alpes, Grenoble, France.

Gilles Barone-Rochette (G)

Department of Cardiology, University Hospital, Grenoble Alpes, Grenoble, France.
Univ. Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, Grenoble, France.
French Alliance Clinical Trial, French Clinical Research Infrastructure Network, Paris, France.

Classifications MeSH